Featured Blog
-
September 09, 2024
This phase III interventional, randomized, open-label trial investigates the safety and efficacy of a new second-line treatment for advanced or metastatic breast cancer. Treating advanced or metastat...
Browse blogs by hospital
Share this
All Blogs
-
December 03, 2017
By MedStar Health Research Institute
As part of the MedStar Health commitment to our associates and our goal of supporting continuous learning and professional development, the following classes are now open for registration through Orga...
-
December 03, 2017
By MedStar Health Research Institute
In April 2018, leaders from pharma, biotech, clinical research organizations, health care organizations, advocacy groups and the FDA are convening to deliver on the promise of patient-centric clinical...
-
December 03, 2017
By MedStar Health Research Institute
Abstract submissions for the seventh annual MedStar Health Research Symposium are now open! The Symposium offers the opportunity to connect with researchers, residents, executive leaders, and collabor...
-
December 03, 2017
By MedStar Health Research Institute
We are pleased to announce the 2018-2020 cohort of the MedStar Teaching Scholars. At the heart of the MedStar Teaching Scholars program is MedStar’s commitment to teaching clinician edu...
-
December 03, 2017
Thank you to all associates who donated and stepped out to support Team MCRN at the 2017 American Heart Association Greater Washington Heart Walk. The team raised $1,490 to help Americans build health...
-
December 03, 2017MG-SORC Research Finds Unexpected Results on Medicaid Expansion and Reduction of Disparity in Access
By MedStar Health Research Institute
The research team from the MedStar-Georgetown Surgical Outcomes Research Center (MG-SORC) recently published their findings on mixed effects on pre-ACA Medicaid expansion on access to surgical cancer ...